Guidelines & Advice

Most Popular Documents

See which documents other people are reading and reviewing most often. The list is updated on a regular basis to give you the most current information.

Displaying Most Popular Documents

135 Items

Pemetrexed Monotherapy for the Maintenance Treatment of Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Non-Squamous Histology

Document Status: Archived
ID: CED 21

Jan 2011

Use of Neoadjuvant Chemotherapy in Transitional Cell Carcinoma of the Bladder

Document Status: Archived
ID: 3-2-2 Version 2
Version: 2

Nov 2012

The Use of Cabazitaxel in Men with Castrate Resistant Metastatic Prostate Cancer Previously Treated with Docetaxel

Document Status: Archived
ID: CED 23

Oct 2011

Organizational Requirements for Acute Leukemia Service Providers in Ontario: Recommendations Report 2024

Document Status: Current
Version: 2

Dec 2024

Use of Chemotherapy in Advanced Unresectable or Metastatic Transitional Cell Carcinoma of the Bladder or Urothelium

Document Status: Archived
ID: 3-12

Nov 2011

Dose-intensive Chemotherapy with Growth Factor or Autologous Bone Marrow/Stem Cell Transplant Support in Advanced or Metastatic Adult Soft Tissue Sarcoma

Document Status: Archived
ID: 11-5

Sep 2011

Use of Adjuvant Chemotherapy Following Cystectomy in Patients with Deep Muscle-Invasive Transitional Cell Carcinoma of the Bladder

Document Status: Archived
ID: 3-2-1

Oct 2012

Hepatitis B Virus Screening and Management for Patients Receiving Systemic Treatment

Document Status: Current

Sep 2022

Use of Irinotecan in the Second-Line Treatment of Metastatic Colorectal Cancer

Document Status: Archived
ID: 2-16

Sep 2011

Role of Adjuvant Treatment in Resected Pancreatic Ductal Adenocarcinoma

Document Status: Current
ID: GL 2-33
Version: 2

Updated

Jun 2025

The Role of Neoadjuvant Chemotherapy in the Treatment of Locally Advanced Squamous Cell Carcinoma of the Head and Neck (Excluding Nasopharynx)

Document Status: Archived
ID: 5-1

Apr 2013

Systemic Therapy for Metastatic Urothelial Cancer: An Endorsement of a Portion of the European Association of Urology Guideline on Muscle-Invasive and Metastatic Bladder Cancer

Document Status: In-Review
ID: GL END 3-24

Aug 2022